FDKSX | FNSFX | FDKSX / FNSFX | |
Total Expense Ratio | 1.76 | 0.65 | 271% |
Annual Report Gross Expense Ratio | 1.76 | 0.65 | 271% |
Fund Existence | 11 years | 8 years | - |
Gain YTD | 3.938 | 5.383 | 73% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 715M | 6.52B | 11% |
Annual Yield % from dividends | 0.57 | 1.39 | 41% |
Returns for 1 year | 6.94 | 8.65 | 80% |
Returns for 3 years | 38.58 | 44.43 | 87% |
Returns for 5 years | 36.89 | 45.65 | 81% |
Returns for 10 years | 40.73 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SBHIX | 22.96 | -0.10 | -0.43% |
Saratoga Health & Biotechnology I | |||
RRGCX | 7.28 | -0.05 | -0.68% |
DWS RREEF Global Real Estate Secc C | |||
EKBDX | 13.94 | -0.10 | -0.71% |
Allspring Diversified Cap Bldr Adm | |||
WWICX | 11.90 | -0.09 | -0.75% |
Westwood Income Opportunity C | |||
JLCFX | 70.13 | -0.89 | -1.25% |
JHancock Fundamental Large Cap Core R4 |